Presentations will highlight how contrast-enhanced mammography can be useful in follow-up imaging, how MRI can uncover more information about the effect of the COVID-19 vaccine on adenopathy, how insurance deductibles affect adherence to breast cancer screening, and how photon-counting CT and molecular imaging show potential in breast imaging applications.

AI once again takes center stage as research continues to highlight its potential in breast imaging. Researchers presenting at the RSNA will show the technology's use as a triage tool, as well as alongside radiologists for analyzing suspicious imaging findings. The goal is to reduce workloads and improve cancer detection.

Breast density and its ties to breast cancer risk will be explored too, with its challenging impact on cancer detection and imaging performance to be scrutinized. Researchers at RSNA will also make the case that breast density needs to be better assessed and accounted for in breast cancer screening.

In addition, RSNA 2022 will feature educational courses, both in-person and on-demand, for radiologists of all experience levels on a myriad of topics within breast imaging. The sessions will cover topics such as the best use of AI in clinical practice, molecular subtypes of breast cancer, patient treatment management practices, health disparities and health equity, abbreviated imaging workflows, and emerging technologies, among others. Poster presentations will also be showcased.

Keep reading for highlights of just some of the many presentations scheduled for this year's meeting. You can also access the complete scientific and educational program on the RSNA 2022 website.